Sevelamer |
Renagel; sevelamer hydrochloride |
Sevelamer Systematic (IUPAC) name poly(allylamine- co-N,N'-diallyl-1,3-diamino-2-hydroxypropane) Identifiers CAS number 52757-95-6 ATC code V03AE02 PubChem 3085017 DrugBank APRD01226 Chemical data Formula [(C3H7N)a+b.(C9H17N2O)c]m where a+b:c = 9:1 Mol. weight variable Pharmacokinetic data Bioavailability nil Metabolism nil Half life n/a Excretion faecal 100% Therapeutic considerations Pregnancy cat. B3 (Australia) Legal status Schedule 4 (Austra ...
Wikipedia - [full article]
Sevelamer Clinical Trials
- Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate
ClinicalTrials.gov Identifier: NCT00440648 - Completed
Chronic Kidney Disease
- A Cross-Over Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer Hydrochloride Tablets Dosed Three Times Per Day in Haemodialysis Patients.
ClinicalTrials.gov Identifier: NCT00267514 - Completed
Chronic Kidney Disease; Hemodialysis
- CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
ClinicalTrials.gov Identifier: NCT00211939 - Active, not recruiting
Calcinosis; Arteriosclerosis; Hyperparathyroidism, Secondary
- Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing
ClinicalTrials.gov Identifier: NCT00324376 - Completed
Chronic Kidney Disease
- Head to Head Study Against Sevelamer Hydrochloride
ClinicalTrials.gov Identifier: NCT00441545 - Recruiting
Chronic Kidney Disease, Stage 5
- Open-Label Study to Compare Sevelamer Carbonate Powder Dosed Once Per Day to Sevelamer Hydrochloride Tablets Dosed Three Times Per Day in Patients With Chronic Kidney Disease on Hemodialysis.
ClinicalTrials.gov Identifier: NCT00268957 - Completed
Chronic Kidney Disease; Hemodialysis; Hyperphosphatemia; Chronic Renal Insufficiency; End Stage Renal Disease
- Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate
ClinicalTrials.gov Identifier: NCT00364000 - Not yet recruiting
Haemodialyzed Patients; Hyperphosphatemia
- Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD
ClinicalTrials.gov Identifier: NCT00486772 - Completed
Vascular Diseases
- Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals
ClinicalTrials.gov Identifier: NCT00018135 - Completed
Renal Failure
- Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease
ClinicalTrials.gov Identifier: NCT00151918 - Completed
Kidney Failure, Chronic

Not Signed In -


